Clinical Trials Browser

Phase 2 × Liver Neoplasms × Oxaliplatin × Clear all

NCT03111732 2021-12-03

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Phase 2 Completed

11 enrolled 16 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

NCT01775501 2020-04-22

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

Phase 2 Completed

40 enrolled 12 charts

Gastrointestinal

Liver Neoplasms

NCT00941967 2019-07-10

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00483405 2017-07-12

NRR

Phase 2 Completed

33 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03026803 2017-04-13

A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer

Phase 2 Terminated

4 enrolled 4 charts

Gastrointestinal

Liver Neoplasms

NCT01581307 2017-03-03

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Phase 2 Completed

9 enrolled 8 charts

Gastrointestinal

Liver Neoplasms, Pancreatic Neoplasms

NCT00250822 2011-10-05

Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

Phase 2 Completed

Gastrointestinal

Liver Neoplasms, Neoplasms

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms